drugset / Trial / NCT05250791
Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This feasibility (small) study aims to see if it is possible to run a large study looking at the effect of lidocaine on large bowel cancer recurrence after surgery in the NHS hospitals.
Timeline
- Start
- 2023-02-02
- Primary completion
- 2024-09-15
- Completion
- 2024-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 1.5 mg/kg | Intravenous |